(New York Times) – Yet despite decades of research, no treatment has been created that arrests Alzheimer’s cognitive deterioration, let alone reverses it. That dismal lack of progress is partly because of the infinite complexity of the human brain, which has posed insurmountable challenges so far. Scientists, funders and drug companies have struggled to justify billions in costs and careers pursuing dead-end paths. But there’s another, sinister, factor at play.

Over the past 25 years, Alzheimer’s research has suffered a litany of ostensible fraud and other misconduct by world-famous researchers and obscure scientists alike, all trying to ascend in a brutally competitive field. During years of investigative reporting, I’ve uncovered many such cases, including several detailed for the first time in my forthcoming book. (Read More)